Breaking News: Dr. Reddy’s Laboratories Launches Treprostinil Injection in the U.S.
Dr. Reddy’s Launches Treprostinil Injection in U.S. Market Introduction Dr. Reddy’s Laboratories Ltd. has made a significant announcement with the launch of Treprostinil Injection in the U.S. market. This generic version of Remodulin® (treprostinil) Injection has been approved by the U.S. Food and Drug Administration (USFDA), marking a milestone for the company. About Dr. Reddy’s…